25 Patent Results (22 families)
Make Note

Compositions And Methods

  • Published: Jun 7, 2012
  • Filed: Dec 5, 2011
  • Earliest Priority: Dec 03 2010
  • Family: 2
  • Cited Works: 107
  • Cited by: 6
  • Cites: 1
  • Sequences: 238
  • Additional Info: Cited Works Full text Published Sequence
  • Applicant: Genome Res Ltd, Liu Pentao, Khaled Walid, Burke Shannon, Lee Song-choon
Patent Application
WO 2012/073047 A2
054-230-362-553-423

Methods For Molecular Classification Of Brca-like Breast And/or Ovarian Cancer

  • Published: Jun 4, 2015
  • Filed: Nov 28, 2014
  • Earliest Priority: Nov 28 2013
  • Family: 3
  • Cited Works: 37
  • Cited by: 0
  • Cites: 10
  • Sequences: 129
  • Additional Info: Cited Works Full text Published Sequence
  • Applicant: Stichting Het Nl Kanker Inst Antoni Van Leeuwenhoek Ziekenhuis, Agendia N V
Patent Application
WO 2015/080585 A1
135-372-375-808-19X

Er-stress Inducing Compounds And Methods Of Use Thereof

  • Published: Apr 19, 2016
  • Filed: Oct 18, 2013
  • Earliest Priority: Oct 19 2012
  • Family: 1
  • Cited Works: 64
  • Cited by: 0
  • Cites: 0
  • Sequences: 3
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: Whitehead Institute For Biomedical Research
  • Applicant: Whitehead Biomedical Inst
Granted Patent
US 9316631 B1
173-029-941-449-989

A Method For Predicting A Breast Cancer Patient's Response To Anthracycline Treatment

  • Published: Nov 22, 2017
  • Filed: May 20, 2016
  • Earliest Priority: May 20 2016
  • Family: 3
  • Cited Works: 43
  • Cited by: 0
  • Cites: 1
  • Sequences: 9
  • Additional Info: Cited Works Sequence
  • Applicant: Klinikum Rechts Der Isar Der Technischen Universität München, Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt Gmbh
Patent Application
EP 3246413 A1
076-012-139-963-721

Combination Therapy With Glutaminase Inhibitors

  • Published: Jun 27, 2017
  • Filed: Jun 12, 2015
  • Earliest Priority: Jun 13 2014
  • Family: 15
  • Cited Works: 52
  • Cited by: 6
  • Cites: 28
  • Additional Info: Cited Works Full text
  • Owner: Calithera Biosciences Inc
  • Applicant: Calithera Biosciences Inc
Granted Patent
US 9687485 B2
056-824-051-142-88X

Diagnosis And Therapy Of Cancer Involving Cancer Stem Cells

  • Published: Feb 5, 2015
  • Filed: Jul 31, 2013
  • Earliest Priority: Jul 31 2013
  • Family: 16
  • Cited Works: 7
  • Cited by: 3
  • Cites: 2
  • Sequences: 12
  • Additional Info: Cited Works Full text Published Sequence
  • Applicant: Biontech Ag, Ganymed Pharmaceuticals Ag, Tron Translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg Universität Mainz Ge
Patent Application
WO 2015/014376 A1
053-564-713-128-845

Interference Peptides And Use Thereof

  • Published: Feb 12, 2019
  • Filed: Oct 20, 2014
  • Earliest Priority: Oct 20 2014
  • Family: 2
  • Cited Works: 18
  • Cited by: 0
  • Cites: 4
  • Sequences: 23
  • Additional Info: Cited Works Full text Sequence
  • Owner: The University Of Western Australia
  • Applicant: Univ Western Australia
Granted Patent
US 10201610 B2
090-962-204-532-976

Diagnosis And Therapy Of Cancer Involving Cancer Stem Cells

  • Published: Feb 5, 2015
  • Filed: Jul 30, 2014
  • Earliest Priority: Jul 31 2013
  • Family: 16
  • Cited Works: 8
  • Cited by: 2
  • Cites: 2
  • Sequences: 12
  • Additional Info: Cited Works Full text Published Sequence
  • Applicant: Biontech Ag, Ganymed Pharmaceuticals Ag, Tron Translationale Onkologie An Der Universitätsmedizin Der Johannes Gutenberg Universität Mainz Ge
Patent Application
WO 2015/014870 A1
170-698-732-946-881

Patient Stratification And Determining Clinical Outcome For Cancer Patients

  • Published: Apr 24, 2018
  • Filed: Sep 24, 2012
  • Earliest Priority: Sep 23 2011
  • Family: 4
  • Cited Works: 101
  • Cited by: 0
  • Cites: 11
  • Additional Info: Cited Works Full text Published
  • Owner: Agency For Science Technology And Research, National University Of Singapore
  • Applicant: Agency Science Tech & Res, Nat Univ Singapore
Granted Patent
US 9953129 B2
134-296-220-415-668

Cancer Therapy Using Cldn6 Target-directed Antibodies In Vivo

  • Published: Aug 1, 2017
  • Filed: Jul 4, 2011
  • Earliest Priority: Jul 06 2010
  • Family: 24
  • Cited Works: 123
  • Cited by: 3
  • Cites: 79
  • Sequences: 13
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: Ganymed Pharmaceuticals Ag, Johannes Gutenberg-universitat Mainz
  • Applicant: Sahin Ugur, Tureci Ozlem, Koslowski Michael, Walter Korden, Kreuzberg Maria, Luxen Sylvia, Ganymed Pharmaceuticals Ag, Johannes Gutenberg-universitat Mainz
Granted Patent
US 9718886 B2
030-890-629-254-741
{{::'analysis.preview.CITED_WORKS_ANALYSIS.title' | message}} {{::'analysis.preview.view.full' | message}}

Add New Note

Sorry, you can't add a note to multiple items. You can add a note to your search as a saved query. Did you want to save this search and add a note to it?

Cancel Save
Search ORCID

Sign in to the Lens

Forgot Password? Register New Account
Feedback